Evidence map›Paper›PMID 39731618›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025

Fatal dengue virus infection in an unvaccinated traveler.

Jonathan Steinke, Veronica Di Cristanziano, Jan-Hendrik Naendrup, Dániel Cadar, Martin Gabriel, Roger Grosser, Noëlle Sieg, Lisa Altenrath, Jesko Welters, Alexander Simonis and 6 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jonathan Steinke *Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0009-0004-2332-7169
Veronica Di Cristanziano *Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0003-1604-8386
Jan-Hendrik NaendrupDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-6420-7938
Dániel CadarDepartment of Arbovirology and Entomology, Bernhard-Nocht-Institute for Tropical Medicine (BNITM), Hamburg, Germany.ORCID http://orcid.org/0000-0002-8063-2766
Martin GabrielDepartment of Virology, Bernhard-Nocht-Institute for Tropical Medicine (BNITM), Hamburg, Germany.
Roger GrosserWisplinghoff Laboratories, Cologne, Germany.
Noëlle SiegDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Lisa AltenrathDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Jesko WeltersDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Alexander SimonisDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0003-2945-9897
Rosanne SpruteDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0003-2457-6437
Jorge Garcia BorregaDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0003-1326-1560
Gertrud StegerInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-0581-8122
Jonas Schmidt-ChanasitDepartment of Arbovirology and Entomology, Bernhard-Nocht-Institute for Tropical Medicine (BNITM), Hamburg, Germany.ORCID http://orcid.org/0000-0003-4433-0231
Alexander Shimabukuro-VornhagenDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-2351-7294
Henning GruellInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. henning.gruell@uk-koeln.de.ORCID http://orcid.org/0000-0002-0725-7138

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue is an increasing threat to individuals living in or visiting endemic countries. Effective vaccines have become available, but their use in travelers is typically only recommended to individuals with documented prior infection. We present a fatal case of severe dengue in an unvaccinated traveler without known prior dengue virus infection but longitudinal serologic and molecular evidence for secondary infection. In the context of this case and vaccination guidance for travelers, we discuss pre-vaccination screening, potential implications for travelers to regions with ongoing outbreaks, and emphasize the importance of serostatus-independent vaccines.

Indexed as

DengueDengue VirusTravelAdultAntibodies, ViralDengue VaccinesFatal OutcomeHumansMaleUnvaccinated PersonsVaccinationAntibodies, ViralDengue Vaccines

Identifiers

PMID39731618
PMCPMC11880070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.